http://orcid.org/0000-0001-8605-0217
References
- Duewall JL, Fenves AZ, Richey DS, et al. 5-oxoproline (pyroglutamic) acidosis associated with chronic acetaminophen use. Proc (Bayl Univ Med Cent). 2010;23:19–20.
- Pitt JJ, Hauser S. Transient 5-oxoprolinuria and high anion gap metabolic acidosis: clinical and biochemical findings in eleven subjects. Clin Chem. 1998;44:1497–1503.
- Liss DB, Paden MS, Schwarz ES, et al. What is the clinical significance of 5-oxoproline (pyroglutamic acid) in high anion gap metabolic acidosis following paracetamol (acetaminophen) exposure?. Clin Toxicol. 2013;51:817–827.
- Zand L, Muriithi A, Nelsen E, et al. Severe anion gap metabolic acidosis from acetaminophen use secondary to 5-oxoproline (pyroglutamic acid) accumulation. Am J Med Sci. 2012;344:501–504.
- Milosevic S, Tran K, O'Brien B. A rare cause of high anion gap metabolic acidosis. Intern Med J. 2013;43:100–101.
- Mårtensson J, Gustafsson J, Larsson A. A therapeutic trial with N‐acetylcysteine in subjects with hereditary glutathione synthetase deficiency (5‐oxoprolinuria). J Inherit Metab Dis. 1989;12:120–130.
- Leung PSC, Tsui SH, Siu TS, et al. Acquired 5-oxoprolinuria (Pyroglutamic acidaemia) as a cause of early high anion gap metabolic acidosis in acute massive paracetamol overdose. Hong Kong J Emerg Med. 2011;18:264–270.
- Armenian P, Gerona RR, Blanc PD, et al. 5-Oxoprolinemia causing elevated anion gap metabolic acidosis in the setting of acetaminophen use. J Emerg Med. 2012;43:54–57.
- Wellner VP, Sekura R, Meister A, et al. Glutathione synthetase deficiency, an inborn error of metabolism involving the gamma-glutamyl cycle in patients with 5-oxoprolinuria (pyroglutamic aciduria). Proc Natl Acad Sci USA. 1974;71:2505–2509.
- Larsson A, Rolf Zetterström R, Hörnell H, Porath U. Erythrocyte glutathione synthetase in 5-oxoprolinuria: kinetic studies of the mutant enzyme and detection of heterozygotes. Clin Chim Acta. 1976;73:19–23.
- Tokatlı A, Kalkanoğlu-Sivri HS, Yüce A, et al. Acetaminophen induced hepatotoxicity in a glutathione synthetase-deficient patient. Turk J Pediatr. 2007;49:75–76.
- Xia H, Ye J, Wang L, et al. A case of severe glutathione synthetase deficiency with novel GSS mutations. Braz J Med Biolog Res. 2018;51:e6853.
- Larsson A, Mattsson B, Wauters EAK, et al. 5-Oxoprolinuria due to hereditary 5-oxoprolinase deficiency in two brothers: a new inborn error of the gamma-glutamyl cycle. Acta Paediatr Scand. 1981;70:301–308.
- Henderson MJ, Larsson A, Carlsson B, et al. 5-Oxoprolinuria associated with 5-oxoprolinase deficiency; further evidence that this is a benign disorder. J Inherit Metab Dis. 1993;16:1051–1052.
- Hlozek T, Krizek T, Tuma P, et al. Quantification of paracetamol and 5-oxoproline in serum by capillary electrophoresis: implication for clinical toxicology. J Pharmaceut Biomed Anal. 2017;145:616–620.
- Ghezzi P, Garattini S, Caccia S, et al. Plasma pyroglutamic acid levels after oral administration of monosodium glutamate to human volunteers. Toxicol Lett. 1983;15:123–129.